This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Dana-Farber-Cancer Institute Inc., Medical University of Lodz, The Brigham and Women's Hospital, Inc.. Active years: 2022-2025.
Company Filing History:
2 out of 1,266 
2 out of 2 
2 out of 1,425 
Years Active: 2022-2025
Title: The Innovations of Konrad Stawiski
Introduction
Konrad Stawiski is a notable inventor based in Lodz, Poland. He has made significant contributions to the field of medical research, particularly in the area of cancer diagnostics. His work focuses on the development of innovative methods for detecting ovarian cancer through microRNA biomarkers.
Latest Patents
Stawiski holds two patents related to his groundbreaking research. His latest patents include methods and kits for determining the presence or absence of specific microRNA biomarkers in blood samples from female patients. These biomarkers are closely associated with ovarian cancer. The patents also outline methods for screening female subjects for these biomarkers, as well as treatment options for those diagnosed with ovarian cancer.
Career Highlights
Throughout his career, Stawiski has worked with prestigious institutions such as the Dana-Farber Cancer Institute and Brigham and Women's Hospital. His experience in these renowned organizations has allowed him to collaborate with leading experts in the field of oncology and contribute to advancements in cancer research.
Collaborations
Some of his notable coworkers include Dipanjan Chowdhury and Kevin M. Elias. Their collaborative efforts have further enhanced the impact of Stawiski's research in the medical community.
Conclusion
Konrad Stawiski's innovative work in the detection and treatment of ovarian cancer through microRNA biomarkers showcases his dedication to advancing medical science. His contributions are paving the way for improved diagnostic methods and treatment options for patients.